GSK vaccine brief pending
Pharmaceutical giant GlaxoSmithKline has put the global account for cervical cancer vaccine Cervarix out to pitch.
The six-figure PR account is currently held by Cohn & Wolfe. It is
understood to include issues work and public affairs activity in most
global markets outside the US.
GSK's vaccine hit the headlines in June when the Department of Health
ADVERTISEMENT
chose it over rival Sanofi Pasteur's product for use in a schoolgirl
vaccination programme.
GSK is in discussions with agencies. It will then create a shortlist and
brief agencies for a pitch before Christmas.
Clew Communications handles the core UK PR brief for Cervarix and is not
affected.
Jobs
- STAFFING AGENCY :: INTEGRATED AGENCY, Dylan*
- ,
- CEO, PPA
- Six Figure basic, Central London
- ACCOUNT EXECUTIVE :: EXPERIENTIAL, Dylan*
- Good Benefits, Central London
Comments